InflaRx N.V.
corporate_fare Company Profile
InflaRx N.V. (NASDAQ:IFRX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for IFRX at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- InflaRx Receives Nasdaq Delisting Warning for Sub-$1.00 Share Price
- InflaRx Cuts 30% Workforce, Restructures to Extend Cash Runway to Mid-2027 and Focus on Izicopan
Financial Snapshot
Insider Transactions
IFRX files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.